Last reviewed · How we verify

Procedural death 1 — Competitive Intelligence Brief

Procedural death 1 (Procedural death 1) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Cardiovascular.

phase 3 Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Procedural death 1 (Procedural death 1) — The First Affiliated Hospital of Henan University of Science and Technology. Procedural death 1 is a drug that aims to prevent or reduce the risk of death during medical procedures.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Procedural death 1 TARGET Procedural death 1 The First Affiliated Hospital of Henan University of Science and Technology phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Procedural death 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/procedural-death-1. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: